Whitehawk Therapeutics Inc [WHWK] stock is trading at $1.61, down -6.67%. An important factor to consider is whether the stock is rising or falling in short-term value. The WHWK shares have gain 8.78% over the last week, with a monthly amount drifted -1.83%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Whitehawk Therapeutics Inc [NASDAQ: WHWK] stock has seen the most recent analyst activity on August 27, 2024, when Piper Sandler downgraded its rating to a Neutral and also revised its price target to $1.75 from $5. Previously, TD Cowen downgraded its rating to Hold on August 21, 2024. On August 21, 2024, downgrade downgraded it’s rating to Hold and revised its price target to $1.50 on the stock. H.C. Wainwright downgraded its rating to a Neutral. Jefferies initiated its recommendation with a Buy and recommended $45 as its price target on January 11, 2022. In a note dated September 14, 2021, Ladenburg Thalmann initiated an Buy rating and provided a target price of $51 on this stock.
Whitehawk Therapeutics Inc [WHWK] stock has fluctuated between $1.21 and $3.81 over the past year. Whitehawk Therapeutics Inc [NASDAQ: WHWK] shares were valued at $1.61 at the most recent close of the market.
Analyzing the WHWK fundamentals
Whitehawk Therapeutics Inc [NASDAQ:WHWK] reported sales of 25.98M for the trailing twelve months, which represents a growth of 14.43%. Gross Profit Margin for this corporation currently stands at -1.08% with Operating Profit Margin at -2.6%, Pretax Profit Margin comes in at -2.45%, and Net Profit Margin reading is -2.45%. To continue investigating profitability, this company’s Return on Assets is posted at -0.91, Equity is -0.88 and Total Capital is -1.27. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.5567 points at the first support level, and at 1.5033 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.7167, and for the 2nd resistance point, it is at 1.8233.
Ratios To Look Out For
For context, Whitehawk Therapeutics Inc’s Current Ratio is 3.59. On the other hand, the Quick Ratio is 3.28, and the Cash Ratio is 1.68. Considering the valuation of this stock, the price to sales ratio is 2.90, the price to book ratio is 0.76.
Transactions by insiders
Recent insider trading involved BALL BRYAN, that happened on Mar 03 ’25 when 2147.0 shares were sold. CHIEF FINANCIAL OFFICER, Giacobello Scott M. completed a deal on Mar 03 ’25 to sell 2806.0 shares. Meanwhile, CHIEF EXECUTIVE OFFICER Lennon David James sold 5690.0 shares on Mar 03 ’25.
